These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 9708599)

  • 21. Policy analysis of the conversion of histamine2 antagonists to over-the-counter use.
    Kalish SC; Bohn RL; Avorn J
    Med Care; 1997 Jan; 35(1):32-48. PubMed ID: 8998201
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prescription drugs: issues of cost, coverage, and quality.
    Copeland C
    EBRI Issue Brief; 1999 Apr; (208):1-21. PubMed ID: 10539445
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A 30-month evaluation of the effects on the cost and utilization of proton pump inhibitors from adding omeprazole OTC to drug benefit coverage in a state employee health plan.
    West DS; Johnson JT; Hong SH
    J Manag Care Pharm; 2006; 12(1):25-32. PubMed ID: 16420105
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The demise of Oregon's Medically Needy program: effects of losing prescription drug coverage.
    Zerzan J; Edlund T; Krois L; Smith J
    J Gen Intern Med; 2007 Jun; 22(6):847-51. PubMed ID: 17380369
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of drug sample removal on prescribing in a family practice clinic.
    Hartung DM; Evans D; Haxby DG; Kraemer DF; Andeen G; Fagnan LJ
    Ann Fam Med; 2010; 8(5):402-9. PubMed ID: 20843881
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Trends in prescription drug expenditures by Medicaid enrollees.
    Banthin JS; Miller GE
    Med Care; 2006 May; 44(5 Suppl):I27-35. PubMed ID: 16625061
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Medicaid prescription drug coverage: state efforts to control costs.
    Gencarelli DM
    NHPF Issue Brief; 2003 May; (790):1-17. PubMed ID: 12751504
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Substitution between prescribed and over-the-counter medications.
    Leibowitz A
    Med Care; 1989 Jan; 27(1):85-94. PubMed ID: 2911221
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of insurance status on pain medication prescriptions in a hematology/oncology practice.
    Holcombe RF; Griffin J
    South Med J; 1993 Feb; 86(2):151-6. PubMed ID: 8434284
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prescription drugs: recent trends in utilization, expenditures, and coverage.
    Sethi RC
    EBRI Issue Brief; 2004 Jan; (265):1-35. PubMed ID: 14969223
    [No Abstract]   [Full Text] [Related]  

  • 31. Over-the-counter drugs as a new managed care benefit.
    Scheur BS; Aaron RM
    Med Interface; 1997 Feb; 10(2):88-94. PubMed ID: 10164797
    [TBL] [Abstract][Full Text] [Related]  

  • 32. States' control of prescription drug spending: a heterogeneous approach.
    Morden NE; Sullivan SD
    Health Aff (Millwood); 2005; 24(4):1032-8. PubMed ID: 16012143
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Results of a retrospective database analysis of drug utilization and costs for treatment of chronic hepatitis B virus infection in the northern Netherlands between 2000 and 2006.
    Tu HA; Bos JH; Woerdenbag HJ; Visser ST; Wilschut JC; van Assen S; de Jong-van den Berg LT; Postma MJ
    Clin Ther; 2010 Jan; 32(1):133-44. PubMed ID: 20171419
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An evaluation of prescribing trends and patterns of claims within the Preferred Drugs Initiative in Ireland (2011
    McDowell R; Bennett K; Moriarty F; Clarke S; Barry M; Fahey T
    BMJ Open; 2018 Apr; 8(4):e019315. PubMed ID: 29678966
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Physicians' prescribing responses to a restricted formulary: the impact of Medicaid preferred drug lists in Illinois and Louisiana.
    Virabhak S; Shinogle JA
    Am J Manag Care; 2005 Jan; 11 Spec No():SP14-20. PubMed ID: 15700905
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The elimination of selected drug products from the Michigan Medicaid formulary: a case study.
    Smith DM; McKercher PL
    Hosp Formul; 1984 May; 19(5):366-72. PubMed ID: 10299510
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of Medicaid drug-payment limits on admission to hospitals and nursing homes.
    Soumerai SB; Ross-Degnan D; Avorn J; McLaughlin Tj; Choodnovskiy I
    N Engl J Med; 1991 Oct; 325(15):1072-7. PubMed ID: 1891009
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effects of copayments and generic substitution on the use and costs of prescription drugs.
    Smith DG
    Inquiry; 1993; 30(2):189-98. PubMed ID: 8314607
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Short-term impacts of coverage loss in a Medicaid population: early results from a prospective cohort study of the Oregon Health Plan.
    Carlson MJ; DeVoe J; Wright BJ
    Ann Fam Med; 2006; 4(5):391-8. PubMed ID: 17003137
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prescription drug coverage and seniors: how well are states closing the gap?
    Safran DG; Neuman P; Schoen C; Montgomery JE; Li W; Wilson IB; Kitchman MS; Bowen AE; Rogers WH
    Health Aff (Millwood); 2002; Suppl Web Exclusives():W253-68. PubMed ID: 12703581
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.